Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities-Reference-Cited by-同舟云学术

Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities

Published:2015-11 Issue:48 Volume:290 Page:29022-29034
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Losdyck Elisabeth,Hornakova Tekla,Springuel Lorraine,Degryse Sandrine,Gielen Olga,Cools Jan,Constantinescu Stefan N.,Flex Elisabetta,Tartaglia Marco,Renauld Jean-Christophe,Knoops Laurent

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference33 articles.

1. Jak1 has a dominant role over Jak3 in signal transduction through γc-containing cytokine receptors;Haan;Chem. Biol,2011

2. The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction;Saharinen;J. Biol. Chem,2002

3. Mapping of a region within the N terminus of Jak1 involved in cytokine receptor interaction;Haan;J. Biol. Chem,2001

4. Critical sites for the interaction between IL-2Rγ and JAK3 and the following signaling;Tang;Biochem. Biophys. Res. Commun,2001

5. Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain;Cacalano;EMBO J,1999

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Repositioning via Graph Neural Networks: Identifying Novel JAK2 Inhibitors from FDA-Approved Drugs through Molecular Docking and Biological Validation;Molecules;2024-03-19

2. Janus Kinase 3 (JAK3): A Critical Conserved Node in Immunity Disrupted in Immune Cell Cancer and Immunodeficiency;International Journal of Molecular Sciences;2024-03-04

3. N-Acetylcysteine Alters Disease Progression and Increases Janus Kinase Mutation Frequency in a Mouse Model of Precursor B-Cell Acute Lymphoblastic Leukemia;Journal of Pharmacology and Experimental Therapeutics;2024-02-09

4. Machine Learning-Based Drug Repositioning of Novel Janus Kinase 2 Inhibitors Utilizing Molecular Docking and Molecular Dynamic Simulation;Journal of Chemical Information and Modeling;2023-10-31

5. N-Acetylcysteine alters disease progression and increases Janus Kinase mutation frequency in a mouse model of precursor B cell acute lymphoblastic leukemia;2023-10-20